Johnson & Johnson to Acquire Actelion in $30 Billion Deal

U.S. pharmaceutical company Johnson & Johnson has agreed to acquire Actelion Pharmaceuticals, Europe’s biggest biotech company, for $30 billion, the companies said.

from WSJ.com: US Business http://ift.tt/2jzT4sb
via IFTTT